Fokas, E., Yoshimura, M., Prevo, R., Higgins, G., Hackl, W., Maira, S., . . . Muschel, R. J. (2012). NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity. Radiation oncology (London, England), 7(1), 48. https://doi.org/10.1186/1748-717X-7-48
Citácia podle Chicago (17th ed.)Fokas, Emmanouil, Michio Yoshimura, Remko Prevo, Geoff Higgins, Wolfgang Hackl, Sauveur-Michel Maira, Eric J. Bernhard, WGillies McKenna, a Ruth J. Muschel. "NVP-BEZ235 and NVP-BGT226, Dual Phosphatidylinositol 3-kinase/mammalian Target of Rapamycin Inhibitors, Enhance Tumor and Endothelial Cell Radiosensitivity." Radiation Oncology (London, England) 7, no. 1 (2012): 48. https://doi.org/10.1186/1748-717X-7-48.
Citácia podľa MLA (8th ed.)Fokas, Emmanouil, et al. "NVP-BEZ235 and NVP-BGT226, Dual Phosphatidylinositol 3-kinase/mammalian Target of Rapamycin Inhibitors, Enhance Tumor and Endothelial Cell Radiosensitivity." Radiation Oncology (London, England), vol. 7, no. 1, 2012, p. 48, https://doi.org/10.1186/1748-717X-7-48.